sulfamethoxypyridazine has been researched along with Jaundice, Neonatal in 1 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Jaundice, Neonatal: Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DUNN, PM | 1 |
1 other study available for sulfamethoxypyridazine and Jaundice, Neonatal
| Article | Year |
|---|---|
THE POSSIBLE RELATIONSHIP BETWEEN THE MATERNAL ADMINISTRATION OF SULPHAMETHOXYPYRIDAZINE AND HYPERBILIRUBINAEMIA IN THE NEWBORN.
Topics: Female; Humans; Hyperbilirubinemia; Infant; Infant, Newborn; Jaundice; Jaundice, Neonatal; Maternal- | 1964 |